| Name | Smith's Pharmacy #94 |
|---|---|
| Organization Name | Smiths Food & Drug Centers Inc |
| Location | 455 S 500 E, Salt Lake City, Utah 84102 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (801) 328-6033 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A new study from the Abramson Cancer Center and Department of Psychiatry in the University of Pennsylvania School of Medicine shows that smokers who carry a particular version of a gene for an enzyme that regulates dopamine in the brain may suffer from concentration problems and other cognitive deficits when abstaining from nicotine - a problem that puts them at risk for relapse during attempts to quit smoking.
A new study determined that children and adolescents with seizures involving the temporal lobe are likely to have clinically significant behavioral problems and psychiatric illness, especially depression.
VantAI and TARA Biosystems today announced the launch of a biology-driven, AI-enabled collaboration for accelerated cardiac drug development.
Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Massachusetts, in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-influenza (flu) drugs, including those that may be effective against potentially pandemic influenza strains like H5N1.
A drug policy researcher is proposing a suite of changes to overhaul the Multi-Criteria Drug Harm Scale, which informs drug policies across Europe.
› Verified 4 days ago
| NPI Number | 1336164961 |
| Organization Name | SMITHS FOOD & DRUG CENTERS INC |
| Doing Business As | SMITHS PHARMACY #94 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 455 S 500 E, Salt Lake City, UT 84102 |
| Phone Number | 801-328-6033 |
News Archive
A new study from the Abramson Cancer Center and Department of Psychiatry in the University of Pennsylvania School of Medicine shows that smokers who carry a particular version of a gene for an enzyme that regulates dopamine in the brain may suffer from concentration problems and other cognitive deficits when abstaining from nicotine - a problem that puts them at risk for relapse during attempts to quit smoking.
A new study determined that children and adolescents with seizures involving the temporal lobe are likely to have clinically significant behavioral problems and psychiatric illness, especially depression.
VantAI and TARA Biosystems today announced the launch of a biology-driven, AI-enabled collaboration for accelerated cardiac drug development.
Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Massachusetts, in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-influenza (flu) drugs, including those that may be effective against potentially pandemic influenza strains like H5N1.
A drug policy researcher is proposing a suite of changes to overhaul the Multi-Criteria Drug Harm Scale, which informs drug policies across Europe.
› Verified 4 days ago
News Archive
A new study from the Abramson Cancer Center and Department of Psychiatry in the University of Pennsylvania School of Medicine shows that smokers who carry a particular version of a gene for an enzyme that regulates dopamine in the brain may suffer from concentration problems and other cognitive deficits when abstaining from nicotine - a problem that puts them at risk for relapse during attempts to quit smoking.
A new study determined that children and adolescents with seizures involving the temporal lobe are likely to have clinically significant behavioral problems and psychiatric illness, especially depression.
VantAI and TARA Biosystems today announced the launch of a biology-driven, AI-enabled collaboration for accelerated cardiac drug development.
Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Massachusetts, in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-influenza (flu) drugs, including those that may be effective against potentially pandemic influenza strains like H5N1.
A drug policy researcher is proposing a suite of changes to overhaul the Multi-Criteria Drug Harm Scale, which informs drug policies across Europe.
› Verified 4 days ago
Handspring Clinical Services Type: Prosthetic/Orthotic Supplier Location: 750 E 100 S, Salt Lake City, Utah 84102 Phone: (801) 328-9728 | |
Accredo Health Group Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3488 S Main St, Salt Lake City, Utah 84115 Phone: (801) 832-0222 | |
Albertson's Pharmacy #1708 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 729 N Redwood Rd, Salt Lake City, Utah 84116 Phone: (801) 532-3795 | |
Alpine Home Medical Equipment Llc Type: DME Supplier - Oxygen Equipment & Supplies Location: 4030 S State St, Salt Lake City, Utah 84107 Phone: (801) 463-0044 | |
Amerita, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2446 S Progress Dr, Salt Lake City, Utah 84119 Phone: (801) 908-6100 |